The Ambulatory Medical Assistance (AMA) programme during active-phase treatment in patients with haematological malignancies: A cost-effectiveness analysis.

Anne-Sophie MichalletStephanie MalartreElodie VignaudAlexiane BocquetPascale SontagChristelle GalvezJean-Yves BlayPierre HeudelAlexandre VimontMartin BlachierMarie FerruaEtienne MinvielleOlivier Mir

Published in: European journal of cancer care (2022)

The AMA programme was shown to be cost-effective compared to a simulated control arm with no intervention.

Keyphrases

study protocol
randomized controlled trial
blood pressure
healthcare
replacement therapy
smoking cessation